The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The youngest population under 50 years old (P50) with lung cancer (LC) in the French nationwide real-life KBP cohorts: Evolution since 2000.
 
Lionel Falchero
No Relationships to Disclose
 
Thomas Laurent
No Relationships to Disclose
 
Jean Quieffin
No Relationships to Disclose
 
Herve Pegliasco
No Relationships to Disclose
 
Serge Jeandeau
No Relationships to Disclose
 
Caroline Clarot
No Relationships to Disclose
 
Hong Rabut
No Relationships to Disclose
 
Fanny Magne
No Relationships to Disclose
 
Jean-Philippe Kraemer
No Relationships to Disclose
 
Sébastien Larive
No Relationships to Disclose
 
Jean-Michel Peloni
No Relationships to Disclose
 
Alexa Mairovitz
No Relationships to Disclose
 
Catherine Marichy
No Relationships to Disclose
 
Vincent Tack
No Relationships to Disclose
 
Philippe Bonnefoy
No Relationships to Disclose
 
Kheir Eddin Benmammar
No Relationships to Disclose
 
Soraya Bordier
No Relationships to Disclose
 
Hugues Morel
No Relationships to Disclose
 
Didier Debieuvre
Honoraria - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; pfizer; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Ipsen; Janssen; MSD Oncology; Novartis; OSE Immunotherapeutics; Pfizer Hellas; Sanofi/Aventis
Research Funding - AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Chiesi; Chugai Pharma; GlaxoSmithKline; Janssen; Lilly; MSD Avenir; Novartis; OSE Immunotherapeutics; Pfizer; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche; Takeda